Recently, several studies using animal models of MS, AD, SCI and traumatic brain injury (TBI) have set out to examine whether microglial cell function and activity are affected by the Nogo-A/NgR signaling pathway. This evidence concerns the gene RTN4 and Alzheimer disease.